Investigating the role of a specific enzyme in heart tissue healing after injury
Role of Pck2 in cardiac fibrosis
This study is looking at how certain heart cells called fibroblasts help heal the heart after a heart attack, focusing on a specific enzyme that might help these cells get the energy they need to do their job better, with the hope of finding new treatments to reduce scarring and improve heart health for patients with heart failure.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisville NIH-funded |
| Lab location | 1 site (Louisville, United States) |
| Project ID | NIH-10913593 on NIH RePORTER |
What this research studies
This research focuses on understanding how fibroblasts, which are crucial for heart tissue repair after a heart attack, change their behavior and metabolism during the healing process. It examines the role of the enzyme Pck2 in these cells, particularly how it may help them meet increased energy and building block demands during tissue remodeling. By studying these metabolic pathways, the research aims to identify potential targets for therapies that could reduce excessive scarring in the heart. Patients may benefit from insights that could lead to new treatments for heart failure resulting from cardiac fibrosis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced a myocardial infarction and are at risk of developing cardiac fibrosis.
Not a fit: Patients who have not had a heart attack or do not have any cardiovascular conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies to prevent or reduce heart tissue scarring after a heart attack.
How similar studies have performed: Previous research has shown that targeting metabolic pathways in fibroblasts can influence their behavior, suggesting that this approach may yield promising results.
Where this research is happening
Louisville, United States
- University of Louisville — Louisville, United States (Active)
Researchers
- Principal investigator: Wells, Collin — University of Louisville
- Study coordinator: Wells, Collin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.